These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7715074

  • 1. [Initiation of hematopoietic recovery by recombinant human granulocyte-macrophage colony-stimulating factor in a case of severe aplastic anemia induced by gold salt].
    Murai K, Michimata M, Shimosegawa K, Oikawa H, Utsugisawa T, Narigasawa Y, Miyairi Y, Kuriya S.
    Rinsho Ketsueki; 1995 Jan; 36(1):23-8. PubMed ID: 7715074
    [Abstract] [Full Text] [Related]

  • 2. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
    Ippoliti C, Przepiorka D, Giralt S, Andersson BS, Wallerstein RO, Gutterman J, Deisseroth AB, Champlin RE.
    Bone Marrow Transplant; 1993 Jan; 11(1):55-9. PubMed ID: 8094309
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppression as initial treatment for gold induced aplastic anemia.
    Mant MJ, Russell AS, Percy JS, Davis P, Messner HA.
    J Rheumatol; 1987 Oct; 14(5):1026-9. PubMed ID: 3123673
    [Abstract] [Full Text] [Related]

  • 4. [Streptomycin-induced severe aplastic anemia successfully treated with high-dose methylprednisolone pulse therapy and rhG-CSF].
    Umeno Y, Miyamoto Y, Ohta Y.
    Rinsho Ketsueki; 1993 Nov; 34(11):1491-3. PubMed ID: 7504752
    [Abstract] [Full Text] [Related]

  • 5. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF].
    Higashino K, Kito K, Hodohara K, Fujiyama Y, Banba T, Hosoda S.
    Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235
    [Abstract] [Full Text] [Related]

  • 6. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, Batlle M, Rozman C.
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.
    Colombat P, Delain M, Desbois I, Domenech J, Binet C, Tabah I, Lamagnere JP, Linassier C.
    Bone Marrow Transplant; 1996 Aug; 18(2):293-9. PubMed ID: 8864437
    [Abstract] [Full Text] [Related]

  • 9. Antithymocyte globulin in the treatment of gold induced severe aplastic anemia.
    Alvaro-Gracia JM, Castañeda-Sanz S, Arranz R, Ariza A, Sabando P, Ossorio C.
    J Rheumatol; 1988 Jan; 15(1):43-5. PubMed ID: 3127586
    [Abstract] [Full Text] [Related]

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 11. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin].
    Yasuyama M, Kawauchi K, Sugiyama H, Ohkawa S.
    Rinsho Ketsueki; 2000 Jan; 41(1):42-7. PubMed ID: 10695398
    [Abstract] [Full Text] [Related]

  • 12. [Severe pancytopenia in old age after 12-month ACE inhibitor therapy].
    Schratzlseer G, Lipp T, Riess G, Antoni D, Delius W.
    Dtsch Med Wochenschr; 1994 Jul 29; 119(30):1029-33. PubMed ID: 7519541
    [Abstract] [Full Text] [Related]

  • 13. [Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment].
    Marín P, Rovira M, Sanz C, Montserrat E, Rozman C.
    Sangre (Barc); 1990 Oct 29; 35(5):397-9. PubMed ID: 2127137
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 29; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma.
    Fay JW, Bernstein SH.
    Semin Oncol; 1996 Apr 29; 23(2 Suppl 4):22-7. PubMed ID: 8600545
    [Abstract] [Full Text] [Related]

  • 16. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R, Okamoto S, Takahashi S, Inoue T, Kikuno K, Aoki Y, Takada M, Irie S, Shimane M, Tojo A.
    Rinsho Ketsueki; 1993 Aug 29; 34(8):946-51. PubMed ID: 8105115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF).
    Robak T, Krykowski E, Warzocha K.
    Arch Immunol Ther Exp (Warsz); 1994 Aug 29; 42(5-6):433-8. PubMed ID: 8572903
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.